Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on April 7, 2009
JNCI Journal of the National Cancer Institute 2009 101(8):539; doi:10.1093/jnci/djp102
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
101/8/539-b    most recent
djp102v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2009.

MEMO TO THE MEDIA

More Intensive Treatment Not Associated with Better Outcomes in Early Bladder Cancer

The first 10% of the full text of this article appears below.

Patients with early bladder cancer who receive more intensive treatment within the first two years of diagnosis do not appear to have better survival than patients who receive less intensive treatment, according to a retrospective analysis published in the April 7 online issue of the Journal of the National Cancer Institute. . . [Full Text of this Article]

Citations:

Contacts:


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Provider Treatment Intensity and Outcomes for Patients With Early-Stage Bladder Cancer
Brent K. Hollenbeck, Zaojun Ye, Rodney L. Dunn, James E. Montie, and John D. Birkmeyer
J Natl Cancer Inst 2009 101: 571-580. [Abstract] [Full Text] [PDF]

Does Treatment Intensity Matter in Superficial Bladder Cancer? Consensus, Clinical Practice, and Confounding
Gary H. Lyman, Nicole M. Kuderer, and Stephen J. Freedland
J Natl Cancer Inst 2009 101: 543-545. [Extract] [Full Text] [PDF]